Latest news with #DevenChoksey
Economic Times
12 hours ago
- Business
- Economic Times
Deven Choksey on 3 insurance stocks to invest in now
Deven Choksey, MD, DRChoksey FinServ Pvt. Ltd, says private sector insurance companies remain relatively more favourable from the growth perspective because their base is giving them an advantage at this point of time. Would Choksey immediately buy some of these stocks? The answer is both yes and no. Valuation-wise, some of them have already started scaling up. There is good potential in SBI and HDFC Life and also Bajaj Life from an investment perspective. ADVERTISEMENT Where do you see the insurance sector moving ahead and which are your top favourites? Deven Choksey: The private sector companies have been thriving on the product innovations, they have been thriving on the high value added product at the same time, and also adopting the digital approach in expanding the marketplace. The cost of acquiring a customer remains comparatively lower in their case. Given that situation, I think they deserve to be premium ranked which they are currently. The embedded value to EBITDA ratio that we look at in life insurance remains comfortably high for some of the private insurers compared to LIC. In my view, the growth momentum is expected to continue for a couple of reasons. One, the new income tax exemptions have started coming in this financial year, wherein the tax rates are not likely to apply till the amount of income is up to Rs 12 lakh and that is where the higher amount of surplus remaining in the hands of individuals would possibly find its way in some of the financial products including the life insurance. In this scenario, the private sector companies remain relatively more favourable from the growth perspective also because of the fact that their base is giving them an advantage at this point of time. Would we immediately buy some? The answer is yes and no both. Valuation-wise, some of them have already started scaling up. We find good potential in the likes of SBI and HDFC Life and also Bajaj Life Insurance business. We like those businesses from an investment perspective. What about the pharma sector? It has been steadily gaining market momentum, but I believe the market is not factoring in the big tariff overhang on pharma. What are you making of this space? Deven Choksey: That remains uncertain for sure, till the time we get full clarity on it. But leaving that aside, how are Indian companies strategizing their presence across the globe? On one hand, they are bringing out the specialty generics, the complex generics that some of the large companies like Sun Pharma, Cipla, Dr Reddy's among others are registering their presence in. The complex generics drugs are giving them the advantage of pricing power. As far as the pricing is concerned on this particular drug, because they are not competing with pure generic, that is a positive for them and most of these companies are expanding their portfolio on that side. The second positive which is going in is API business, which is again very comfortably getting merged into the formulation business some of the global peers, the large pharma companies, and again Indian companies including the likes of Divi's, Laurus, and even the other majors. Last but not the least, on the margin front, since the input cost scenario is improving, most of these pharma companies are seeing better margins in the current financial year vis-à-vis previous years. So, we remain distinctly confident about the prospects going forward despite the tariff turbulence. Once that is out of the way, some of these companies could get rerated. (You can now subscribe to our ETMarkets WhatsApp channel)
Economic Times
14-05-2025
- Business
- Economic Times
New lifetime high on cards for Nifty? Deven Choksey's market outlook amid rally
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel As the markets display resilience amid the recent geopolitical tensions, investors remain curious if the market will hit a fresh lifetime high in the current leg of the rally? As markets continue to surge amid positive momentum, Deven Choksey , MD of DRChoksey FinServ, in an interaction with ETNow, shared his perspective on where the indices could be headed next and the sectors likely to drive the market in the coming pointed out that the direction (of the market) remains positive despite the sharp rise in the previous session and suggested that a potential correction could present fresh buying opportunities for stated, "We probably would see the higher contribution into the index stocks, particularly from index stocks into the indexes," indicating that heavyweights in the IT sector may start providing a higher amount of push compared to the recent reliance on BFSI and Reliance noted the possibility of Nifty moving up to 25,200 in the near term and consolidating between the 24,200 to 25,200 range before making further moves. However, he cautioned that the money market would take some time to pull off and adjust to this particular rise, indicating that some amount of correction could be asked about stock recommendations given the current earnings season, Choksey maintained a cautious stance on midcaps and smallcaps, preferring to stay 'a little bit more protective' with a focus on larger identified IT, pharmaceuticals, and metals as sectors that could possibly give the momentum-based push to Nifty 50 stocks . Additionally, he expressed confidence in select BFSI stocks, highlighting their potential for a higher amount of growth driven by improving profit the broader market outlook , Choksey remarked that input costs in the manufacturing segment have remained under control unlike last year, while the demand scenario in capital goods has shown signs of improvement. This, he noted, could be a positive for manufacturing companies in the near response to a query about potential buys, Choksey did not specify a particular stock but mentioned that IT and pharma stocks, particularly those benefiting from the recent trade deal with China, are currently available at corrective price and could present attractive buying opportunities."I would consider buying into the portfolio now and not going for later," he added, indicating a selective and price-conscious approach in the current market environment.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Time of India
14-05-2025
- Business
- Time of India
New lifetime high on cards for Nifty? Deven Choksey's market outlook amid rally
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel As the markets display resilience amid the recent geopolitical tensions, investors remain curious if the market will hit a fresh lifetime high in the current leg of the rally? As markets continue to surge amid positive momentum, Deven Choksey , MD of DRChoksey FinServ, in an interaction with ETNow, shared his perspective on where the indices could be headed next and the sectors likely to drive the market in the coming pointed out that the direction (of the market) remains positive despite the sharp rise in the previous session and suggested that a potential correction could present fresh buying opportunities for stated, "We probably would see the higher contribution into the index stocks, particularly from index stocks into the indexes," indicating that heavyweights in the IT sector may start providing a higher amount of push compared to the recent reliance on BFSI and Reliance noted the possibility of Nifty moving up to 25,200 in the near term and consolidating between the 24,200 to 25,200 range before making further moves. However, he cautioned that the money market would take some time to pull off and adjust to this particular rise, indicating that some amount of correction could be asked about stock recommendations given the current earnings season, Choksey maintained a cautious stance on midcaps and smallcaps, preferring to stay 'a little bit more protective' with a focus on larger identified IT, pharmaceuticals, and metals as sectors that could possibly give the momentum-based push to Nifty 50 stocks . Additionally, he expressed confidence in select BFSI stocks, highlighting their potential for a higher amount of growth driven by improving profit the broader market outlook , Choksey remarked that input costs in the manufacturing segment have remained under control unlike last year, while the demand scenario in capital goods has shown signs of improvement. This, he noted, could be a positive for manufacturing companies in the near response to a query about potential buys, Choksey did not specify a particular stock but mentioned that IT and pharma stocks, particularly those benefiting from the recent trade deal with China, are currently available at corrective price and could present attractive buying opportunities."I would consider buying into the portfolio now and not going for later," he added, indicating a selective and price-conscious approach in the current market environment.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Time of India
13-05-2025
- Business
- Time of India
Expect a big move in metals; stick to quality largecaps: Gautam Shah
Live Events You Might Also Like: Metal stocks surge over 8% as US-China tariff truce lifts market sentiment You Might Also Like: Pharma and metals could drive next leg of momentum: Deven Choksey (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel , Founder,, says gold's surge past expectations suggests a short-term peak around $3450-3500, requiring consolidation before further also says metals are poised for a significant rally. Experts predict the metals index will reach 10,500. Top-tier metal producers, especially in steel and non-ferrous sectors, are favoured. Jindal Group stocks are particularly attractive. These leading stocks could see gains between 15% and 30%. Investors should focus on quality large-caps to navigate global I am sure the gold has actually done the unthinkable. I remember 18 months back at various conferences, it was trading at levels of $1800 and nobody had the visibility that it could actually cross $3000. But in charts it gave you some sense that a mega trend was coming. For now, the trend is done with, $3450-3500 is a short-term top. It needs multiple weeks of consolidation before it can do bigger things. The longer term is invested in gold but do not be a buyer at these prices. You will get a little more dip closer to levels of $2900-3000. But the bigger trade for the next one year which again we have been saying for a while now is silver. Silver seems to be consolidating and what gold has done over the last one-and-a-half years, silver can do over the next 12 to 18 months. So once the metal gets past, you are going to see a mega trend there.I do not think it can get back to its heyday, but it will not go down too much, that itself is a win for the IT index. Remember, many of these stocks are very richly valued. Many of these stocks have a lot to do with foreign soil. And in today's complex and volatile world, it might not be easy for IT stocks to get into a structural while they might see a pullback from time to time, I do not think they are going to take leadership anytime soon. In the next leg of the market moving towards lifetime highs, new leaders will emerge. Maybe financial services will do better. Metals will do well. Real estate will do well. The entire PSU basket will do well where the valuations are very comfortable. So, while we like it, we are not recommending it as a structural trade for the rest of the would be metals. Last summer that same trade was financial services and Bajaj Finance and some of these top stocks worked out quite well because they stood out while the entire mess was getting cleaned and cleared. Now the metals index after yesterday's big move on charts, tells me that there is something brewing behind the scene that fundamentally could trigger a big move. So, chartically, I am very convinced that the metals index is heading towards 10,500.I am sticking to top quality everywhere, in each of these sectors of the market I am looking at the big boys because they can create alpha and in this complex global world, you do not want to be very picky with midcaps and smallcaps where the trend is very shallow. Any volatility and midcaps and small caps tend to fall. But the top steel producers are the ones which we really like. In fact, even in the non-ferrous metal stocks, we like the top three or four names. The entire Jindal Group of stocks we like. In this basket, all the top five or six stocks can appreciate anywhere between 15% and 30%.
Time of India
13-05-2025
- Business
- Time of India
Pharma and metals could drive next leg of momentum: Deven Choksey
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel "When the momentum is back, the market is crazy about the midcaps and smallcaps . I would like to stay a little bit more protective at this point of time as far as the portfolio construction is concerned and would probably continue to stay with some of the larger companies," says Deven Choksey , MD, DRChoksey FinServ Pvt. the fabric is woven as far as the market direction is concerned. Though the yesterday's rise has been significantly large as I would like to call it as and money market would take some time to pull off and adjust to this particular going forward the direction remains clear. We probably would see the higher contribution into the index stocks, particularly from index stocks into the indexes and that would include some of the heavy weights in IT space per se where I believe that could probably start giving the little higher amount of push as against the earlier push of only BFSI and Reliance last few if the IT stock starts supporting the index, then possibility of 25,200 on Nifty in the following times is distinctly there and should be cross about 25,200 and stay in that particular region between 24,200 to 25,200 on Nifty, maybe one would see that the market consolidating and by the second half would take initiative to go a little further up, but at this point of time direction remains some amount of correction in the indices is definitely due because the sharp rise has happened yesterday and that correction could possibly a good opportunity for investors to buy into the when the momentum is back, the market is crazy about the midcaps and smallcaps. I would like to stay a little bit more protective at this point of time as far as the portfolio construction is concerned and would probably continue to stay with some of the larger couple of sectors where the immediate rise including the momentum may support, one of them would be IT, second could be pharma, and third could be metals. They could possibly give the momentum based push as well into the Nifty 50 stocks, but over and above that we continue to hold our positions in some of the good quality BFSI companies where we believe that higher amount of growth is going to drive the profit performance of these companies the manufacturing space, we remain distinctly clear on two-three aspects, on one side the input cost is remaining under control unlike last year and on the other side the demand scenario, the business are improving, particular for capital good segment as a we remain distinctly positive on that front as well. Yes, but we should be selective, very-very selective in the midcap space where we like some of the companies, but if the valuations are expensive, probably we would decide before buying into them, that is the approach that we have taken in our portfolio it is a good point. I do not know immediately the answer to that one stock. But certainly as I was making a point that some of the IT and pharma companies remain relatively more appealing today because of the trade deal which has been signed with China as well, so more certainty has come on that too sure whether I would buy a 10% more into some of the IT, pharma. They are currently available at corrective price, so to an extent I would consider buying into the portfolio now and not going for later.
